- Home
- LTRX vs SNTI Comparison
LTRX vs SNTI Comparison
Compare LTRX & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- SNTI
- Stock Information
- Founded
- LTRX 1989
- SNTI 2016
- Country
- LTRX United States
- SNTI United States
- Employees
- LTRX N/A
- SNTI N/A
- Industry
- LTRX Computer Communications Equipment
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- LTRX Telecommunications
- SNTI Health Care
- Exchange
- LTRX Nasdaq
- SNTI Nasdaq
- Market Cap
- LTRX 85.6M
- SNTI 85.3M
- IPO Year
- LTRX 2000
- SNTI N/A
- Fundamental
- Price
- LTRX $2.52
- SNTI $2.17
- Analyst Decision
- LTRX Strong Buy
- SNTI Strong Buy
- Analyst Count
- LTRX 5
- SNTI 2
- Target Price
- LTRX $5.10
- SNTI $8.50
- AVG Volume (30 Days)
- LTRX 266.0K
- SNTI 342.2K
- Earning Date
- LTRX 05-08-2025
- SNTI 08-12-2025
- Dividend Yield
- LTRX N/A
- SNTI N/A
- EPS Growth
- LTRX N/A
- SNTI N/A
- EPS
- LTRX N/A
- SNTI N/A
- Revenue
- LTRX $143,159,000.00
- SNTI N/A
- Revenue This Year
- LTRX N/A
- SNTI N/A
- Revenue Next Year
- LTRX $3.61
- SNTI $150.00
- P/E Ratio
- LTRX N/A
- SNTI N/A
- Revenue Growth
- LTRX N/A
- SNTI N/A
- 52 Week Low
- LTRX $1.91
- SNTI $1.52
- 52 Week High
- LTRX $4.55
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- LTRX 60.21
- SNTI 33.12
- Support Level
- LTRX $2.28
- SNTI $2.56
- Resistance Level
- LTRX $2.62
- SNTI $3.40
- Average True Range (ATR)
- LTRX 0.13
- SNTI 0.43
- MACD
- LTRX 0.02
- SNTI -0.09
- Stochastic Oscillator
- LTRX 80.00
- SNTI 2.33
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.